Advertisement

Ads Placeholder
Loading...

Biofrontera Inc.

BFRI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.98
$0.06(6.41%)
U.S. Market opens in 0h 56m

Biofrontera Inc. (BFRI) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.4M
P/E Ratio-1.08
EPS (TTM)$-1.04
ROE-11.39%
Fundamental Analysis

AI Price Forecasts

1 Month$0.82
3 Months$0.49
1 Year Target$14.53

BFRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.08 and a market capitalization of 11.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.41%
5-Day Change
22.49%
1-Month Change
9.51%
3-Month Change
35.16%
6-Month Change
-8.42%
Year-to-Date (YTD) Change
35.16%
1-Year Change
24.45%
3-Year Change
-92.20%
5-Year Change
-98.89%
All-Time (Max) Change
-98.89%

Contact Information

https://www.biofrontera.us.com
781 245 1325
120 Presidential Way, Woburn, MA, 01801

Company Facts

920 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions